TrialPediatric blood & cancer2018

Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.

Christopher C Dvorak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.